Skip to content
Open access

Arrhythmia recurrence following PVI with cardioneuromodulation: insights from a cohort of patients with both bradycardia and paroxysmal atrial fibrillation

Oct 2026 · European Heart Journal · Vol 47 · 0 citations

TL;DR

In this study, CNM was safe and produced measurable autonomic modulation in 2/3 of patients, captured by an immediate stable heart-rate rise >10 bpm, and emerged as marker of higher recurrence risk.

Abstract

Cardiac neuromodulation (CNM) aims to rebalance cardiac autonomic tone by targeting atrial ganglionated plexi. Predictors of atrial fibrillation (AF) recurrence and the durability of autonomic response after CNM combined with pulmonary vein isolation remain uncertain. To identify predictors of AF recurrence and to test the hypothesis that an immediate stable heart-rate (HR) rise after CNM is associated with lower recurrence in patients with paroxysmal AF and profound resting sinus bradycardia. We conducted a retrospective study of 33 consecutive patients who underwent combined CNM + pulmonary veins isolation for AF (2019–2025). Baseline comorbidities, medications and symptoms were recorded. Primary endpoint was AF recurrence documented by ECG or ambulatory monitoring. Immediate autonomic response was predefined as a stable HR rise >10 bpm between the last pre-ablation and first post-ablation measurements. Comparisons used t-tests or Fisher’s exact test, as appropriate. Missing data were analysed as observed without imputation. Mean age was 59.8 ± 12.5 years and 51.5% were male. Hypertension 63.6%, dyslipidaemia 51.5%, diabetes 12.1%. Palpitations were present in 88%. The mean number of ablated plexi at first procedure was 2.44 ± 1.22. Patients with recurrence were younger (52.8 ± 15.2 vs 61.6 ± 10.8 years; one-sided p = 0.047, Figure 1). No major complications occurred during the procedures. An immediate HR rise ≥ 10 bpm occurred in 22/33 (66.7%) and was associated with a lower AF recurrence rate (27% vs 55%; p = 0.03, Figure 2). Neither classic left atrium high-rate stimulation, vagal extracardiac stimulation, nor targeting ≥3 versus ≤2 plexuses were associated with AF recurrence on univariate testing (all p > 0.10). No major procedural complications occurred. In this study, CNM was safe and produced measurable autonomic modulation in 2/3 of patients, captured by an immediate stable HR rise >10 bpm. AF recurrence was not linked to most baseline or procedural variables, but younger age and the absence of acute HR rise emerged as marker of higher recurrence risk. Validation in larger, prospective cohorts with systematic HR variability acquisition and predefined procedural endpoints are needed to refine candidate selection and optimise CNM durability.AF_CNA_1AF_CNA_2

Read PDF

Similar papers

Open access Oct 2026

Autonomic imbalance and structural remodeling predict recurrence after AF ablation: prospective analysis combining HRV and clinical parameters

Predictors of atrial fibrillation (AF) recurrence after catheter ablation remain incompletely understood. While structural atrial remodeling is a recognized determinant of outcome, the contribution of pre-procedural autonomic nervous system activity has not been fully clarified. We aimed to evaluate whether auton...

S. Hassouna, P. Osmančík, D. Heřman et al. · 0 citations
Open access Oct 2026

REVERSE-AF Score: development of a clinical tool to predict atrial fibrillation recurrence after electrical cardioversion

Electrical cardioversion (ECV) restores sinus rhythm in atrial fibrillation (AF), yet recurrence within 12 months remains frequent. Metabolic, respiratory and structural atrial factors, along with age and arrhythmia duration, may critically influence long-term rhythm maintenance. To characterize a real-wor...

C. Costa, I. C. Ines Cruz, T. A. Tiago Aguiar et al. · 0 citations
Open access 2026

Predictive role of left atrial strain in atrial fibrillation recurrence following electrical cardioversion: Results from a 24-month follow-up

Introduction. Left atrial (LA) strain has emerged as a potential marker of atrial mechanical dysfunction and recurrence risk after electrical cardioversion (ECV). This study evaluated the prognostic value of baseline LA strain parameters and LA stiffness index (LASI) for atrial fibrillation (AF) recurrence during 24-mo...

N. Mlaco-vrazalic, Ada Dozić, B. Aziri et al. · 0 citations
Open access Oct 2026

Hemodynamic and Metabolic Predictors of Unsuccessful Electrical Cardioversion or Early Atrial Fibrillation Recurrence After Electrical Cardioversion

Background: Rhythm control remains a cornerstone in the management of atrial fibrillation (AF). Although electrical cardioversion (ECV) effectively restores sinus rhythm (SR), its short-term durability is limited. Aims: This study aimed to evaluate the short-term rhythm outcomes after ECV and to identify predictors of...

P. Skalska, M. Kurpaska, B. Uziębło-Życzkowska et al. · 0 citations
Open access Oct 2026

Early electrical cardioversion for early recurrent atrial tachyarrhythmia after pulmonary vein isolation in atrial fibrillation: a global real-world analysis

Pulmonary vein isolation (PVI) is a well-established procedure for treating atrial fibrillation (AF); however, early recurrence of atrial tachyarrhythmias (ERAT) is common. Electrical cardioversion (ECV) is one treatment for ERAT, but optimal timing is unestablished. To evaluate the association between the...

L. Serio, A. Askarinejad, T. Bucci et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.